Literature DB >> 1929505

Heart-lung transplantation for cystic fibrosis. 1: Assessment.

B Whitehead1, P Helms, M Goodwin, I Martin, B Lask, E Serrano, J P Scott, R L Smyth, T W Higenbottam, J Wallwork.   

Abstract

Forty five patients with cystic fibrosis (age 5-15 years) were assessed for heart-lung transplantation between September 1987 and March 1990. The two main conditions for acceptance were (i) life expectancy less than 2 years and (ii) a severely impaired quality of life. Patients were accepted onto an active waiting list (n = 26), a provisional waiting list (n = 15), or not accepted (n = 4). Selection was made on clinical grounds with objective measurements used as an aid in assessment. As expected, the mean values for objective measures were significantly different between patients on the active waiting list compared with the provisional waiting list/not accepted group for resting heart rate (118/minute v 101/minute), percentage of ideal weight (83.2% v 93.1%), forced expiratory volume at one second as percent of predicted normal (27.3% v 47.6%), Shwachman-Kulczycki score (33.6 v 52.5), Chrispin-Norman x ray score (25.8 v 22.1), 12 minute walk (540 m v 854 m), and minimal oxygen saturation (81.5% v 92%). Psychological evaluation demonstrated a 55% incidence of individual and a 50% incidence of family morbidity. Of the 26 patients accepted onto the active waiting list, 11 have been transplanted (mean waiting time 3.3 months), 10 have died within a mean of 3.7 months of acceptance, and five remain on the active list (mean 5.6 months).

Entities:  

Mesh:

Year:  1991        PMID: 1929505      PMCID: PMC1793053          DOI: 10.1136/adc.66.9.1018

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  27 in total

1.  Heart/lung recipient becomes first living heart donor in United States.

Authors:  B Merz
Journal:  JAMA       Date:  1987-06-12       Impact factor: 56.272

2.  Prognostic factors associated with patient survival during nutritional rehabilitation in malnourished children and adolescents with cystic fibrosis.

Authors:  L Levy; P Durie; P Pencharz; M Corey
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986-01       Impact factor: 2.839

3.  The importance of cytomegalovirus in heart-lung transplant recipients.

Authors:  J A Hutter; J Scott; T Wreghitt; T Higenbottam; J Wallwork
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

4.  Are sex, age at diagnosis, or mode of presentation prognostic factors for cystic fibrosis?

Authors:  I Hudson; P D Phelan
Journal:  Pediatr Pulmonol       Date:  1987 Sep-Oct

5.  Psychosocial sequelae of stoma surgery for inflammatory bowel disease in childhood.

Authors:  B Lask; J Jenkins; L Nabarro; I Booth
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

6.  Transplantation of liver, heart, and lungs for primary biliary cirrhosis and primary pulmonary hypertension.

Authors:  J Wallwork; R Williams; R Y Calne
Journal:  Lancet       Date:  1987-07-25       Impact factor: 79.321

7.  Heart-lung transplantation: better use of resources.

Authors:  J A Hutter; P Despins; T Higenbottam; S Stewart; J Wallwork
Journal:  Am J Med       Date:  1988-07       Impact factor: 4.965

8.  Heart-lung transplantation for cystic fibrosis.

Authors:  J Scott; T Higenbottam; J Hutter; M Hodson; S Stewart; A Penketh; J Wallwork
Journal:  Lancet       Date:  1988-07-23       Impact factor: 79.321

9.  Determination of red-cell mass in assessment and management of anaemia in babies needing blood transfusion.

Authors:  H M Phillips; B M Holland; A Abdel-Moiz; S Fayed; J G Jones; T L Turner; C A Wardrop; F Cockburn
Journal:  Lancet       Date:  1986-04-19       Impact factor: 79.321

10.  Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis.

Authors:  N N Huang; D V Schidlow; T H Szatrowski; J Palmer; L R Laraya-Cuasay; W Yeung; K Hardy; L Quitell; S Fiel
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

View more
  5 in total

1.  A prognostic model for the prediction of survival in cystic fibrosis.

Authors:  K M Hayllar; S G Williams; A E Wise; S Pouria; M Lombard; M E Hodson; D Westaby
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Paediatric lung transplantation: the agony and the ecstasy.

Authors:  B F Whitehead; M R De Leval
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

3.  Heart-lung transplantation for patients under 10 with cystic fibrosis.

Authors:  I M Balfour-Lynn; I Martin; B F Whitehead; P G Rees; M J Elliott; M R de Leval
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

4.  Subdural empyema due to Burkholderia cepacia: an unusual complication after lung transplantation for cystic fibrosis.

Authors:  I M Balfour-Lynn; H C Ryley; B F Whitehead
Journal:  J R Soc Med       Date:  1997       Impact factor: 18.000

5.  Heart-lung transplantation for cystic fibrosis. 2: Outcome.

Authors:  B Whitehead; P Helms; M Goodwin; I Martin; J P Scott; R L Smyth; T W Higenbottam; J Wallwork; M Elliott; M de Leval
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.